ctrl K

Price Alert

Cue Biopharma Inc. (CUE)

NASDAQ: CUE · Real-Time Price · USD

0.81

0.02 (2.53%)

At close: Aug 15, 2025, 3:59 PM

0.83

2.48%

After-hours: Aug 15, 2025, 04:46 PM EDT

Cue Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.46M	48.51M	51.61M	64.37M
Short-Term Investments	n/a	n/a	24.67M	n/a
Long-Term Investments	152K	151K	150K	150K
Other Long-Term Assets	2.06M	2.81M	3.24M	2.86M
Receivables	945K	1.7M	57.25K	3.14M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	805K	1.24M	217.00	n/a
Total Current Assets	25.14M	51.45M	77.19M	68.47M
Property-Plant & Equipment	4.84M	7.12M	10.7M	11.92M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.05M	10.08M	14.1M	14.93M
Total Assets	32.19M	61.53M	91.28M	83.4M
Account Payables	2.82M	3.5M	2.73M	2.59M
Deferred Revenue	85K	2.11M	n/a	645.35K
Short-Term Debt	4.33M	3.96M	1.96M	1.97M
Other Current Liabilities	n/a	1.92M	535.00	38.31K
Total Current Liabilities	13.69M	17.08M	11.55M	12.79M
Long-Term Debt	n/a	4.2M	8.04M	n/a
Other Long-Term Liabilities	n/a	n/a	-658	n/a
Total Long-Term Liabilities	1M	7.36M	14.05M	5.12M
Total Liabilities	14.69M	24.45M	25.6M	17.91M
Total Debt	8.88M	14.7M	19.32M	10.05M
Common Stock	62K	47K	43.04K	32.2K
Retained Earnings	-341.86M	-301.19M	-250.46M	-197.45M
Comprehensive Income	n/a	n/a	-95.87K	n/a
Shareholders Equity	17.5M	37.09M	65.68M	65.49M
Total Investments	152K	151K	24.67M	150K